Neuroscience
The exciting research that may cure Parkinson’s
GeneCode is developing a drug it hopes won't just alleviate Parkinson's symptoms but also protect and restore patient's neural health.
What hybrid mouse/rat brains are showing us about the mind
Modified mice with hybrid brains that include rat neurons could one day lead to new breakthroughs in neuroscience.
How sensory gamma rhythm stimulation clears amyloid in Alzheimer’s mice
Study finds stimulating a brain rhythm with light and sound increases peptide release from interneurons, possibly slowing Alzheimer's progression.
Brain implant for “artificial vision” is still working after 2 years
A new type of brain implant technology has given a man with total blindness a kind of “artificial vision.”
Why a neurodivergent team will be a golden asset in the AI workplace
Since AI is chained to linear reasoning, workplaces that embrace it will do well to have neurodivergent colleagues who reason more creatively.
In a future with brain-computer interfaces like Elon Musk’s Neuralink, we may need to rethink freedom of thought
In a future with more "mind reading," thanks to computer-brain interfaces, we may need to rethink freedom of thought.
Old drug appears to halt progression of Parkinson’s motor symptoms
A GLP-1 agonist used to treat diabetes appeared to halt the progression of Parkinson’s symptoms in a phase 2 trial.
“Universal” BCI lets anyone play games with their minds
A specially trained “decoder” slashes the time it takes a brain-computer interface (BCI) to read a user’s mind.
Oxytocin’s effects aren’t just about love
At last, neuroscientists are learning how the hormone shapes social behaviors such as pair-bonding and parental care. It’s more complicated than they thought.
Psychedelic drugs and the law: What’s next?
The push to legalize magic mushrooms, MDMA, LSD, and other hallucinogens is likely to heighten tensions between state and federal law.